|
2025
|
G/S
|
Pharmaceutical preparations for the treatment of obesity and metabolic diseases and disorders. |
|
|
G/S
|
Pharmaceutical preparations for the treatment of obesity and
metabolic diseases and disorders. |
|
|
G/S
|
Pharmaceutical preparations for the treatment of obesity and metabolic diseases and disorders |
|
|
G/S
|
Pharmaceuticals and medicines for the treatment of obesity and metabolic diseases and disorders. |
|
|
Invention
|
Novel potassium channel opener compounds and related uses. Described herein are potassium channel... |
|
|
G/S
|
Providing supportive personal stories in the field of obesity and obesity disorders via a website... |
|
|
G/S
|
Pharmaceuticals and medicines for the treatment of metabolic
diseases and disorders, including o... |
|
2024
|
Invention
|
Use of melanocortin-4 receptor agonists for the treatment of a lepr and/or sh2b1 deficiency. The ... |
|
|
Invention
|
Sustained release peptide formulations.
This disclosure provides, at least in part, a pharmaceut... |
|
|
Invention
|
Combinations of a potassium channel activator and an mc4r agonist and related methods of use. The... |
|
|
Invention
|
Method of treating melanocortin-4 receptor pathway-associated disorders.
The disclosure is relat... |
|
|
Invention
|
Peptide compositions.
The present invention relates to polypeptide compounds that are modulators... |
|
|
Invention
|
Compositions for treating kidney disease.
The disclosure is related to a method of treating chro... |
|
|
G/S
|
Pharmaceuticals and medicines for the treatment of metabolic
diseases and disorders, namely, obe... |
|
2023
|
G/S
|
Home care services. |
|
|
Invention
|
Methods for treating obesity with an mc4r agonist. The disclosure is related to a method of treat... |
|
|
Invention
|
Methods of treating obesity with an mc4r agonist |
|
|
Invention
|
Novel atp-sensitive potassium channel potentiators, their preparation and use. The present disclo... |
|
|
Invention
|
Novel atp-sensitive potassium channel potentiators, their preparation and use |
|
|
G/S
|
Pharmaceuticals and medicines for the treatment of metabolic diseases and disorders, namely, obes... |
|
|
Invention
|
Methods for treating obesity with an mc4r agonist |
|
|
Invention
|
Method of treating melanocortin-4 receptor-associated disorders in heterozygous carriers.
A meth... |
|
2022
|
G/S
|
Downloadable electronic publications in the nature of flyers and brochures in the field of geneti... |
|
2021
|
Invention
|
Methods of treating melanocortin-4 receptor pathway-associated disorders.
The disclosure is rela... |
|
|
Invention
|
Methods of treating melanocortin-4 receptor pathway-associated disorders. The disclosure is relat... |
|
|
Invention
|
Pharmaceutical compositions. The present invention relates to an ionic complex comprising a catio... |
|
|
G/S
|
Pharmaceuticals and medicines for the treatment of obesity and metabolic diseases and disorders. |
|
|
G/S
|
Pharmaceuticals and medicines for the treatment of obesity
and metabolic diseases and disorders. |
|
|
Invention
|
Method of treating melanocortin-4 receptor pathway-associated disorders. The disclosure is relate... |
|
2020
|
Invention
|
Method of treating melanocortin-4 receptor-associated disorders in heterozygous carriers. A metho... |
|
|
Invention
|
Peptide compositions. The present invention relates to polypeptide compounds that are modulators ... |
|
|
G/S
|
Pharmaceuticals and medicines for the treatment of obesity and metabolic diseases and disorders |
|
|
G/S
|
Conducting seminars in the field of obesity and obesity disorders; educational services, namely, ... |
|
|
G/S
|
Conducting seminars in the field of genetic obesity disorders; educational services, namely, prov... |
|
|
G/S
|
Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids ... |
|
2019
|
G/S
|
Pharmaceuticals and medicines for the treatment of obesity and metabolic diseases and disorders |
|
|
G/S
|
Pharmaceuticals and medicines for the treatment of metabolic diseases and disorders, including ob... |
|
|
G/S
|
Research and product development services in the fields of metabolic diseases and disorders, incl... |
|
|
G/S
|
Printed pamphlets, brochures, leaflets, informational flyers, and informational sheets in the fie... |
|
|
Invention
|
Compositions for treating kidney disease. The disclosure is related to a method of treating chron... |
|
|
G/S
|
Printed leaflets, informational flyers, informational sheets and mailings in the nature of inform... |
|
2018
|
G/S
|
pharmaceuticals and medicines for the treatment of obesity and metabolic diseases and disorders |
|
|
Invention
|
Sustained release peptide formulations. This disclosure provides, at least in part, a pharmaceuti... |
|
|
G/S
|
Pharmaceuticals; Pharmaceuticals and medicines for the treatment of obesity and metabolic disease... |
|
|
G/S
|
Pharmaceuticals and medicines for the treatment of metabolic diseases and disorders, namely obesi... |
|
2014
|
Invention
|
Pharmaceutical compositions. The present invention relates to an ionic complex comprising a... |
